Contract 36C26324D0041
Wells Pharma Of Houston Llc · Department Of Veterans Affairs · August 29, 2024
Wells Pharma Of Houston Llc was awarded a federal contract by Department Of Veterans Affairs on August 29, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 29, 2025. If all options are exercised, the contract could reach $515,000.
Contract details
- PIID
- 36C26324D0041
- Award type
- Indefinite Delivery / Indefinite Quantity
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- August 29, 2024
- Latest action
- September 29, 2025
Description
503B COMPOUNDING PHARMACEUTICALS
Modification timeline
-
September 29, 2025Mod P00004 · Exercise An Option$0
-
January 28, 2025Mod P00003$0
-
August 29, 2024Mod P00002 · Exercise An Option$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Covermymeds Pharmacy Llc | Department Of Veterans Affairs | July 2, 2026 | $16.4K |
| United Therapeutics Corp | Department Of Veterans Affairs | July 2, 2026 | $17.4K |
| Sk Life Science, Inc. | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Theracom, L.L.C. | Department Of Veterans Affairs | July 2, 2026 | $38.1K |
| Cycle Pharmaceuticals Ltd | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Regimed Medical | Department Of Veterans Affairs | July 2, 2026 | $292.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36C26324D0041?
Contract 36C26324D0041 is a federal contract awarded to Wells Pharma Of Houston Llc by Department Of Veterans Affairs on August 29, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 36C26324D0041?
Wells Pharma Of Houston Llc won contract 36C26324D0041 from Department Of Veterans Affairs.
How much is contract 36C26324D0041 worth?
Contract 36C26324D0041 has obligated $0 to date but carries a potential ceiling of $515,000 if fully funded and all options are exercised.